Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
16.26
-0.33 (-1.99%)
At close: Oct 10, 2025, 4:00 PM EDT
16.00
-0.26 (-1.60%)
After-hours: Oct 10, 2025, 5:13 PM EDT

Aardvark Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2024
Period Ending
Jun '25 Dec '24 Dec '23
Cash & Equivalents
2661.649.74
Short-Term Investments
115.8212.020.25
Cash & Short-Term Investments
141.8273.669.99
Cash Growth
-637.44%-
Other Current Assets
2.950.470.38
Total Current Assets
144.7774.1410.37
Net Property, Plant & Equipment
0.520.740.16
Other Long-Term Assets
2.192.640.01
Total Assets
147.4877.5110.54
Accounts Payable
5.062.31.04
Accrued Expenses
4.842.290.24
Current Portion of Leases
0.420.340.11
Total Current Liabilities
10.314.931.38
Long-Term Leases
0.230.440.05
Other Long-Term Liabilities
0.010.030
Total Long-Term Liabilities
0.240.470.05
Total Liabilities
10.555.391.43
Additional Paid-in Capital
218.933.682.94
Accumulated Other Comprehensive Income
-0--
Retained Earnings
-82-58.33-37.74
Total Common Shareholders' Equity
136.93-54.64-34.8
Minority Interest
-126.7643.9
Shareholders' Equity
136.9372.119.1
Total Liabilities & Equity
147.4877.5110.54
Total Debt
0.650.780.16
Net Cash (Debt)
141.1872.889.83
Net Cash Growth
93.70%641.67%-
Net Cash Per Share
-18.242.48
Book Value
136.93-54.64-34.8
Book Value Per Share
--13.67-8.79
Tangible Book Value
136.93-54.64-34.8
Tangible Book Value Per Share
--13.67-8.79
Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q